J&J Expands Russian OTC Foothold Via J.B. Chemicals Portfolio Acquisition
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson expands its consumer health presence in Russia and other Eastern European markets with the acquisition of several OTC brands from J.B. Chemicals & Pharmaceuticals.